Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Automated intraoperative calibration for prostate cancer brachytherapy

View through CrossRef
Purpose:Prostate cancer brachytherapy relies on an accurate spatial registration between the implant needles and the TRUS image, called “calibration”. The authors propose a new device and a fast, automatic method to calibrate the brachytherapy system in the operating room, with instant error feedback.Methods:A device was CAD‐designed and precision‐engineered, which mechanically couples a calibration phantom with an exact replica of the standard brachytherapy template. From real‐time TRUS images acquired from the calibration device and processed by the calibration system, the coordinate transformation between the brachytherapy template and the TRUS images was computed automatically. The system instantly generated a report of the target reconstruction accuracy based on the current calibration outcome.Results:Four types of validation tests were conducted. First, 50 independent, real‐time calibration trials yielded an average of 0.57 ± 0.13 mm line reconstruction error (LRE) relative to ground truth. Second, the averaged LRE was 0.37 ± 0.25 mm relative to ground truth in tests with six different commercial TRUS scanners operating at similar imaging settings. Furthermore, testing with five different commercial stepper systems yielded an average of 0.29 ± 0.16 mm LRE relative to ground truth. Finally, the system achieved an average of 0.56 ± 0.27 mm target registration error (TRE) relative to ground truth in needle insertion tests through the template in a water tank.Conclusions:The proposed automatic, intraoperative calibration system for prostate cancer brachytherapy has achieved high accuracy, precision, and robustness.
Title: Automated intraoperative calibration for prostate cancer brachytherapy
Description:
Purpose:Prostate cancer brachytherapy relies on an accurate spatial registration between the implant needles and the TRUS image, called “calibration”.
The authors propose a new device and a fast, automatic method to calibrate the brachytherapy system in the operating room, with instant error feedback.
Methods:A device was CAD‐designed and precision‐engineered, which mechanically couples a calibration phantom with an exact replica of the standard brachytherapy template.
From real‐time TRUS images acquired from the calibration device and processed by the calibration system, the coordinate transformation between the brachytherapy template and the TRUS images was computed automatically.
The system instantly generated a report of the target reconstruction accuracy based on the current calibration outcome.
Results:Four types of validation tests were conducted.
First, 50 independent, real‐time calibration trials yielded an average of 0.
57 ± 0.
13 mm line reconstruction error (LRE) relative to ground truth.
Second, the averaged LRE was 0.
37 ± 0.
25 mm relative to ground truth in tests with six different commercial TRUS scanners operating at similar imaging settings.
Furthermore, testing with five different commercial stepper systems yielded an average of 0.
29 ± 0.
16 mm LRE relative to ground truth.
Finally, the system achieved an average of 0.
56 ± 0.
27 mm target registration error (TRE) relative to ground truth in needle insertion tests through the template in a water tank.
Conclusions:The proposed automatic, intraoperative calibration system for prostate cancer brachytherapy has achieved high accuracy, precision, and robustness.

Related Results

Nasopharyngeal intracavitary brachytherapy
Nasopharyngeal intracavitary brachytherapy
AbstractBACKGROUNDLocally persistent nasopharyngeal carcinoma (NPC) carries an increased risk of local failure if additional treatment is not given. It has been shown that intracav...
Study on Early Prostate Cancer Antigen (EPCA) and existent risk factors of prostate cancer, Sudan: A case-control study
Study on Early Prostate Cancer Antigen (EPCA) and existent risk factors of prostate cancer, Sudan: A case-control study
Background: Early prostate cancer antigen (EPCA), a nuclear matrix protein, has recently been recommended as a hopeful biomarker for early prostate carcinogenesis. Objectives: To e...
Preliminary study on miRNA in prostate cancer
Preliminary study on miRNA in prostate cancer
Abstract Objective To screen for miRNAs differentially expressed in prostate cancer and prostate hyperplasia tissues and to validate their association with prostate cancer...
Pain and Complications Assessment in Gynecological Cancer Brachytherapy Patients Under Spinal Anesthesia
Pain and Complications Assessment in Gynecological Cancer Brachytherapy Patients Under Spinal Anesthesia
Background: Brachytherapy is a radiation therapy that can deliver radiation to cancer by minimizing radiation exposure to adjacent organs or tissues. In its implementation, brachyt...
Analysis of the spatial distribution and clinical features of prostate cancer in transperineal prostate biopsy
Analysis of the spatial distribution and clinical features of prostate cancer in transperineal prostate biopsy
Abstract Background Recently, most studies on the spatial distribution of the prostate cancer are based on the samples confirmed by transrectal prostate biopsy (TRBx), whic...
Predictive value of prostate calcification for future cancer occurrence: a retrospective long-term follow-up cohort study
Predictive value of prostate calcification for future cancer occurrence: a retrospective long-term follow-up cohort study
Objective: Although prostate calcification is often identified on pelvic CT images, calcification itself is usually not considered clinically significant. A recent histological stu...
Abstract 1341: Identification of significant linkage evidence for lethal prostate cancer on chromosome arm 11p15.
Abstract 1341: Identification of significant linkage evidence for lethal prostate cancer on chromosome arm 11p15.
Abstract We performed genome wide linkage analysis in a set of high-risk prostate cancer pedigrees, each with 3 or more sampled cases whose death certificate indicat...

Back to Top